OCUL Competitors & Alternatives
Compare Ocular Therapeutix Inc with similar stocks in the same industry
Biotechnology
OCUL
Main Stock$9.64
Tradestie Score
58
Market Cap
$1.92B
Revenue Growth
0.0%
Analyst Upside
+181.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.80
|
$2.23B | - | 57 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.19
|
$2.22B | - | 64 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.92
|
$2.21B | - | 61 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.83
|
$2.18B | - | 61 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.38
|
$2.08B | - | 50 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$19.28
|
$2.02B | 54.0 | 56 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$17.56
|
$2.01B | - | 55 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.69
|
$1.97B | - | 63 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$107.95
|
$1.92B | - | 55 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$78.93
|
$1.90B | 466.6 | 55 | Compare |
More OCUL Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry